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Abstract 
There is a lack of an optimal transplant material for small calibre blood vessels. This could be overcome by tissue engineering. 
The optimal construct is to be derived from autologous cells and present mechanical resistance comparable to the gold standard, 
autologous vessels such as the internal mammary artery or the saphenous vein. Our laboratory has developed the self-assembly 
approach to produce tissue sheets that can be rolled into such vessel substitutes. Over the years, many improvements have been 
made to the technique to facilitate smooth muscle cell culture and to produce vascular media substitutes with higher 
circumferential mechanical resistance. 
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1. Introduction 
Cardiovascular diseases are the leading cause of mortality in the USA and coronary heart diseases are 
responsible for half of those death [1]. There is a lack of an optimal transplant material for small caliber blood 
vessels such as the coronary artery. The current gold standard for coronary artery bypass graft (CABG) is the use 
of a vessel from the patient, either the internal mammary artery or the saphenous vein. These vessels are limited in 
availability and are frequently found to be pathologic. Tissue-engineered blood vessels (TEBV) represent a 
valuable alternative for vascular grafts of less than 6 mm in diameter, where synthetic materials are unsuccessful 
since they are frequently thrombogenic. Such TEBV can be reconstructed by the self-assembly approach using the 
capability of mesenchymal cells to produce and assemble collagen into extracellular matrix (ECM). After a few 
weeks of culture in presence of ascorbic acid and serum, the cells form a tissue sheet that can be rolled into a 
tubular construct to form a TEBV [2]. Cytograft® has developed a self-assembled TEBV [3] that have already 
demonstrated interesting results in human clinical trials [4]. The vascular substitute tested in this study was made 
from dermal fibroblasts and seeded with endothelial cells. This TEBV was implanted as an arterio-venous shunt 
for hemodialysis access and was devoid of a media layer.  
Auger’s laboratory has developed a tissue-engineered vascular media (TEVM) made by self-assembly from 
vascular smooth muscle cells (VSMC) [5]. There are two main purposes for TEVM. The first is to use them in 
clinic within TEBV as vascular substitutes for various bypass surgeries or blood vessel replacement. There are 
some advantages in using VSMC instead of dermal fibroblasts for such construct. TEVM possesses contractile 
capabilities, meaning that the construct can adapt itself to blood flow variations. In the normal artery, the media 
layer is responsible for both contraction and compliance of the vessel, therefore it is logical to recreate this layer in 
the tissue-engineered substitute. The second purpose is to use them as model for physiological, pathophysiological, 
pharmacological and toxicological studies. They have been used to study endothelin receptors [6], polyphenol [7-
8] and vascular microparticles [9-10]. In the article by Mostefai et al. [10], these substitutes were used to 
investigate the role of circulating microparticles (MP) in septic shock patients on vascular media. TEVM 
reconstructed with human VSMC treated for 24 hours with MP from septic shock patients caused hyper-reactivity 
to histamine due to a decrease in nitric oxide production. It was also shown that these MP caused an increase of IL-
10 mRNA in VSMC. An endotoxic shock was simulated by lipopolysaccharide (LPS) exposure and caused 
hyporeactivity to histamine in TEVM. In this setting, the concomitant exposure of IL-10 and LPS was able to 
block the vascular hyporeactivity observed after LPS treatment alone. Those results support the usefulness of a 
TEVM for the study of pathological condition in a human model. 
To further improve the mechanical resistance and contractility of the TEVM, Guillemette et al. created a 
physiologic alignment of cells and ECM in the reconstructed tissues. Alignment of cells and ECM within native 
tissues is important for many of their functions such as resistance and contractility. The corneal stroma, vascular 
media, tendons, bones and skeletal muscles are some examples of tissues with precise alignment. This alignment 
can be reproduced in vitro by different methods such as collagen gel compaction, electromagnetic field, 
electrospinning of fibers, microstructured culture plate and mechanical strain [11]. Many of those techniques rely 
on the capability of cells to be directed by contact guidance. Guillemette et al. have developed a microstructured 
culture plate made in a thermoplastic elastomer (TPE) able to support cell culture [12]. This technique has led to 
reconstruction of tissue sheets with improved physiological properties [13].  
Nevertheless, when the self-assembly technique is used with VSMC, the resistance of the resulting tissue sheet 
is variable depending on cell population. To overcome this limitation and produce vascular media with a higher 
success rate using different populations, the original self-assembly technique was adapted by using a decellularized 
matrix scaffold (dMS) produced by self-assembly using human dermal fibroblasts. This scaffold was seeded with 
VSMC and rolled into a TEVM. When the resulting TEVM was compared to the original technique, it was found 
that using this scaffold improved  mechanical and contractile properties, two important parameters for a TEBV 
[14]. 
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2. Methods 
2.1. Cell isolation and culture 
All protocols were approved by the institutional committee for the protection of human subjects (Comité 
d’Éthique de la Recherche du Centre Hospitalier affilié Universitaire de Québec). The human arterial SMCs were 
isolated from the media layer of an umbilical cord artery by the explant method of Ross, as described previously 
[7]. Human dermal fibroblasts (DFs) were isolated from a healthy donor following reducing breast surgery. Cell 
isolation was performed by enzymatic treatment. Thermolysin was used to isolate the dermis from the epidermis 
and then collagenase H, to digest the extracellular matrix, as described previously [14]. All cells were cultured in 
Dulbecco-Vogt modified Eagle’s medium (DMEM, Invitrogen, Burlington, Canada) and Ham’s F12 (Invitrogen) 
in a 3:1 ratio, containing 10% FCS and antibiotics. All cells were grown under 8% CO2 at 37°C and media were 
changed 3 times a week. 
2.2. Production of decellularized matrix scaffold 
Production of decellularized matrix scaffolds (dMS) were performed as described previously [14]. Briefly, DFs 
were cultured for 3 weeks with medium containing ascorbic acid and serum. Tissue sheets were washed several 
times with deionized sterile water and kept in PBS at 4°C until further used. 
2.3. Production of tissue-engineered vascular media constructs 
TEVM constructs were produced as previously described [14]. Briefly, SMCs were seeded on regular cell 
culture flasks to produce standard TEVM (sTEVM) or on dMS to produce the new TEVM (nTEVM). 
2.4. Immunofluorescence 
Five-micrometer thick frozen sections were air-dried, fixed in methanol for 10 minutes at -20ÛC, and rinsed 
with PBS containing 1% bovine serum albumin (BSA, Sigma-Aldrich). Smooth muscle markers labeling was 
made using mouse anti-human -SM-actin (1:100, Dako, Burlington, Canada) and mouse anti-human calponin 
(1:400, Sigma-Aldrich, Oakville, Canada) antibodies for 45 min at room temperature. Alexa Fluor 594-labeled 
goat anti-mouse IgG (1:400; Molecular Probe, Burlington, Canada) was used as a secondary antibody. Hoechst 
33258 (Sigma-Aldrich) was used to counterstain nuclei and tissues were imaged using a epifluorescence 
microscope apparatus (Carl Zeiss, Toronto, ON, Canada). 
3. Results and discussion 
3.1. Immunofluorescence staining of SMC markers 
In order to visualize recellularization of the constructs with SMCs, components of the contractile apparatus, -
SM-actin and calponin, were stained using specific antibodies (Fig. 1). The recellularized dMS (nTEVM) showed a 
uniform distribution of cells within the construct. The expression of those proteins by SMCs suggests that they are 
in a contractile phenotype even in the fibroblastic matrix. 
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Fig. 1. Vascular constructs were stained in red for SMC markers -SM-actin and calponin. nTEVM and sTEVM constructs seeded with SMCs 
stained positive for both of these markers. 
4. Conclusion 
The self-assembly approach is a key concept that has proven over the years to be an effective technique to 
produce models for many types of connective tissues including dermis [15], corneal stroma [16], adipose tissue 
[17], bladder [18], urethral [19] and vascular conduit [20]. Our recent advances in vascular tissue sheet engineering 
include development of scaffold made by self-assembly to support culture of VSMC, which produce low level of 
ECM and the culture of those cells on a microstructured TPE to induce physiological alignment in the resulting 
tissue. 
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